Karin Fijnvandraat

Randomized Trial of Platelet-Transfusion Thresholds in Neonates

Anna Curley, Simon Stanworth, Karen A. Willoughby et al. · New England Journal of Medicine · 2018 · 413 citations · Full text

The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial

Jo Howard, Moira Malfroy, Charlotte Llewelyn et al. · The Lancet · 2013 · 233 citations

Immunohematology, Sickle Cell Disease, Transfusion Medicine +7

Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A

Corien L. Eckhardt, Alice S. van Velzen, Marjolein Peters et al. · Blood · 2013 · 214 citations · Full text

Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1- deamino-8-D-arginine vasopressin in humans

Alessandra Borchiellini, Karin Fijnvandraat, JW ten Cate et al. · Blood · 1996 · 212 citations · Full text

von Willebrand Factor Propeptide in Vascular Disorders: A Tool to Distinguish Between Acute and Chronic Endothelial Cell Perturbation

Jan A. van Mourik, Ria C. Boertjes, I.A. Huisveld et al. · Blood · 1999 · 205 citations